Oral azithromycin vs topical tetracycline
Ocular chlamydia trachomatis infection · people (any age) with active trachoma
1 finding from 1 review
- no estimate extracted3 studies · 5773 participantsLow
Findings
What do systematic reviews say?
64 questions · 65 findings · 10 reviews · Headline outcomes only
No studies found 19 · 29.2%GRADE not reported 4 · 6.2%Very low 10 · 15.4%Low 18 · 27.7%Moderate 14 · 21.5%High 0 · 0%
Oral azithromycin vs topical tetracycline
Antibiotic resistance · people (any age) with active trachoma
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Oral azithromycin vs topical tetracycline
Adverse effects · people (any age) with active trachoma
1 finding from 1 review
- no estimate extracted3 studies · 6002 participantsGRADE not reported
Macrolides vs tetracycline
All‐cause mortality · patients with chronic obstructive pulmonary disease
1 finding from 1 review
- Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 50 participantsGRADE not reported
Macrolides vs tetracycline
Quality of life Drug resistance/microbial sensitivity Serious adverse events Lung function Hospitalisations Adverse events/side effects Number of participants colonised with P aeruginosa · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
- Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Quinolone vs tetracycline
All‐cause mortality · patients with chronic obstructive pulmonary disease
1 finding from 1 review
- Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 50 participantsGRADE not reported
Quinolone vs tetracycline
Quality of life Drug resistance/microbial sensitivity Serious adverse events Lung function Hospitalisations Adverse events/side effects Number of participants colonised with P aeruginosa · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
- Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Doxycycline vs tetracycline
Treatment failure · adults with scrub typhus
It is very uncertain whether doxycycline changes treatment failure compared with tetracycline (very low certainty).
1 finding from 1 review
- RR 6.85 [0.38, 124.38]1 study · 116 participantsVery low
Doxycycline vs tetracycline
Resolution of fever within 48 hours · adults with scrub typhus
Doxycycline showed no clear difference in resolution of fever within 48 hours compared with tetracycline (low certainty).
1 finding from 1 review
- RR 1.14 [0.9, 1.44]1 study · 55 participantsLow
Doxycycline vs tetracycline
Resolution of fever within 5 days · adults with scrub typhus
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Doxycycline vs tetracycline
Time to defervescence · adults with scrub typhus
1 finding from 1 review
- no estimate extracted1 study · 116 participantsLow
Doxycycline vs tetracycline
Serious adverse events · adults with scrub typhus
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Topical metronidazole vs oral (oxy)tetracycline
HRQOL ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Topical metronidazole vs oral (oxy)tetracycline
Participant‐assessed improvement in rosacea severity · Participants with rosacea
1 finding from 1 review
- no estimate extracted3 studies · 182 participantsModerate
Topical metronidazole vs oral (oxy)tetracycline
Proportion of participants with adverse event · Participants with rosacea
1 finding from 1 review
- no estimate extracted4 studies · 258 participantsModerate
Topical metronidazole vs oral (oxy)tetracycline
Physician‐assessed improvement in rosacea severity · Participants with rosacea
1 finding from 1 review
- no estimate extracted2 studies · 81 participantsModerate
Topical metronidazole vs oral (oxy)tetracycline
Assessment of erythema or telangiectasia · Participants with rosacea
1 finding from 1 review
- no estimate extracted4 studies · 258 participantsLow
Topical metronidazole vs oral (oxy)tetracycline
Lesion count · Participants with rosacea
1 finding from 1 review
- no estimate extracted4 studies · 258 participantsModerate
Topical metronidazole vs oral (oxy)tetracycline
Time needed until improvement ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Topical metronidazole vs oral (oxy)tetracycline
Duration of remission ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found